By acting on different epigenetic targets such as oncogenes (Ras and p53 genes) and histone deacetylases (HDACs) [4], these natural products can inhibit CRC cell growth, proliferation, migration, and invasion and increase their sensitivity to anticancer drugs to reduce drug resistance development, inhibiting CRC. Here, TP53 is linked to colorectal carcinoma.